Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Anagenics Limited (AN1.AX)
Sydney, NSW, AU
Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pacific Islands. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +16.67% | +0.00% | +40.00% | +40.00% | +16.67% | -68.18% | -66.67% | -66.67% | -66.67% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%-56.1% Q4'25: -57.7% (vs Q4'23)
-
EPS growth Household & Personal Products: +8.8%+86.2% ★ Q4'25: +103.8% (vs Q4'23)
-
FCF margin FCF growth · Household & Personal Products: +44.8%-27.8% Q4'25: -25.1% (vs Q4'23)
-
EBIT margin Household & Personal Products: +9.9%-25.2% Q4'25: +12.7% (vs Q4'23)
-
ROIC Household & Personal Products: +8.2%-52.4% Q4'25: +45.2% (vs Q4'23)
-
Share dilution Household & Personal Products: +0.2%+17.6% Q4'25: +50.7% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×-0.85× Q4'25: 0.58× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
|---|---|---|---|---|---|---|---|---|
| Revenue |
5.65M
est: 5.60M (+0.9%)
|
7.30M
est: 10.00M (-27.0%)
|
7.38M
est: 16.10M (-54.2%)
|
5.82M
est: 23.30M (-75.0%)
|
6.95M
est: 13.60M (-48.9%)
|
9.11M
est: 19.50M (-53.3%)
|
10.80M
est: 23.30M (-53.6%)
|
4.75M
est: 27.90M (-83.0%)
|
| EBITDA |
-3.07M
est: -2.31M (-32.6%)
|
-5.50M
est: -4.13M (-33.0%)
|
-4.23M
est: -6.65M (+36.5%)
|
-3.90M
est: -9.63M (+59.5%)
|
-2.62M
est: -5.62M (+53.4%)
|
-1.80M
est: -8.06M (+77.6%)
|
-6.60M
est: -9.63M (+31.4%)
|
-994.8K
est: -11.53M (+91.4%)
|
| EBIT |
-3.26M
est: -2.57M (-26.7%)
|
-5.65M
est: -4.59M (-23.1%)
|
-5.04M
est: -7.39M (+31.9%)
|
-4.35M
est: -10.70M (+59.3%)
|
-2.71M
est: -6.24M (+56.6%)
|
-2.16M
est: -8.95M (+75.8%)
|
-7.22M
est: -10.70M (+32.5%)
|
-1.20M
est: -12.81M (+90.7%)
|
| Net Income |
-3.73M
est: -28.56M (+86.9%)
|
-5.91M
est: -9.52M (+37.9%)
|
-4.91M
est: 12.12M (-140.5%)
|
-3.39M
est: 21.64M (-115.7%)
|
-3.65M
est: -3.25M (-12.1%)
|
-2.67M
est: 465.2K (-673.4%)
|
-7.49M
est: 3.72M (-301.4%)
|
-1.24M
|
| SGA |
6.80M
est: 4.74M (+43.3%)
|
7.09M
est: 8.47M (-16.2%)
|
7.20M
est: 13.63M (-47.2%)
|
5.89M
est: 19.73M (-70.1%)
|
6.86M
est: 11.52M (-40.5%)
|
5.88M
est: 16.51M (-64.4%)
|
10.45M
est: 19.73M (-47.0%)
|
2.95M
est: 23.63M (-87.5%)
|
| EPS |
-0.06
est: -0.06 (-2.2%)
|
-0.07
est: -0.02 (-254.9%)
|
-0.05
est: 0.03 (-280.1%)
|
-0.02
est: 0.05 (-151.6%)
|
-0.01
est: -0.01 (-12.5%)
|
-0.01
est: 0.00 (-1,109.1%)
|
-0.02
est: 0.01 (-337.2%)
|
0.00
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Graham Robertson | Head of Research & Development | — | — |
| Hemant Amin | Company Secretary | — | male |
| Michael Worner | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AN1.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
